Efficacy of Kami Guibi-tang as an Add-On Therapy to Acetylcholinesterase Inhibitor for Cognitive Function in Mild Alzheimer's Disease: A Pilot Study. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.